Latest Breaking News On - ஆல்பர்டோ ப்ரேடா - Page 1 : comparemela.com

Share: Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC) Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress. The first abstract titled, Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance, shows the results of a pilot performed at Radboud University Medical Center evaluating the feasibility and clinical outcomes of alternating between cystoscopy/cytology and Bladder EpiCheck in non-muscle invasive bladder cancer (NMIBC) surveillance. To alleviate the burden of invasive and costly standard surveillance methods on patients, urine collection was performed at home and shipped to a central lab to perform the Bladder EpiCheck test. In the pi

United statesComunidad autonoma de catalunaFred witjesAlberto bredaRadboud university medical centerEuropean association of urologyRadboud universityVirtual congressData includes first real world evidenceAlternating bladder epicheckNon muscle invasive bladder cancerBladder epicheckAnnual european associationMedical sciencesRadboud university medicalLung epicheck